SlideShare a Scribd company logo
1 of 27
Download to read offline
Editorial Slides
VP Watch, January 16, 2002, Volume 2, Issue 2
Part II - Animal Models of Heart Attack? Plaque
Rupture/Thrombosis
Part - I
 Cell culture is a convenient way to ask
mechanistic questions, but it lacks complexity of a
real disease thus limiting the scope of testable
hypotheses. Human observations provide rich soil
for making hypotheses, but for obvious ethical
reasons our ability to test these hypotheses in
men is very limited. Animal models are essential
for testing mechanistic hypotheses in a controlled
manner.1
 Ideal animal model is situated in the middle of this
range. 1
1- Japanese
quail
2- Pigeon
3- Chicken
Reported Animal Models for
Atherosclerosis
4- Dog
5- Monkey
6- Pig
7- Rat
8- Rabbit
9- Mouse
 Quail:
- Studies on Japanese quail have shown that the
RES birds were resistant to the disease and
developed little atherosclerosis on a diet
containing 1% cholesterol. The SUS birds were
sensitive and developed severe atherosclerosis in
8-9 wks on a diet containing only 0.5%
cholesterol. 14,15,16
 Pigeon:
- Tesar and Kottke showed that two distinct types of
fatty streaks can be identified in white Carneau
pigeon and their biologic features can be defined
and related to their propensity for atherogenesis.6
 Chicken:
- Wong discussed that chicken is a good animal
model for the study of atherosclerosis research
because it is able to develop spontaneous
atherosclerosis and capable of producing
atherosclerosis after cholesterol feeding with
elevated hypercholesterolemia. There is no
essential difference between vascular lesions
seen in chickens as a result of cholesterol diet and
that of atherosclerosis observed in man.2,3
 Dog:
- Reducing platelet accumulation at sites of balloon
angioplasty may attenuate restenosis. Willerson,
et al. tested this hypothesis by inducing repetitive
platelet aggregation at coronary angioplasty sites
in cholesterol sensitive dogs and measured
subsequent neointima formation. 4,5
 Monkey:
- Blaton and Peeters discussed that the
chimpanzee lipoproteins are useful models for
understanding the relationship between function
and structure of the plasma lipoproteins in health
and disease. Baboon and rhesus monkeys show
similar results, but more differences to the human
lipoproteins in health and disease were
observed.8,9
 Swine:
- Massmann, and others showed relations between
spontaneous and induced arterial lesions in swine
and arteriosclerosis in humans. 7,21
 Rat:
- Bennani-Kabchi et al. showed the potential of the
sand rat to develop atherosclerotic lesions at
different stages which opens the field to
therapeutic tests of new anti-atherogenic agents.
- More recently Herrera et al. demonstrated that
cholesteryl ester transfer protein can be
proatherogenic. The interaction of polygenic
hypertension and hyperlipidemia in the
pathogenesis of atherosclerosis in Tg [hCETP] DS
rats substantiates epidemiological observations in
humans.10,11
 Rabbit:
- Hereditary Watanabe rabbit - Clubb et
al. evaluated temporal distribution of leukocytes,
macrophages, foam cells, vascular smooth
muscle cells, and subendothelial lipid in Watanabe
heritable hyperlipedimic (WHHL) rabbit aortas.19
- Cholesterol fed New Zealand rabbit -
Atherosclerotic plaques were produced in New
Zealand White rabbits by intermittent cholesterol
feeding.20
 Rekhter, et al. have developed a rabbit
model in which an atherosclerotic
plaque can be ruptured at will after an
inflatable balloon becomes embedded
into the plaque. This model as well can
be used for induction of thrombi
associated with plaque rupture. 17
 Mouse:
- The apoE-deficient mouse contains the entire
spectrum of lesions observed during
atherogenesis and is the first mouse model to
develop lesions similar to those in humans. 12,13
Part - II
 The process of atherosclerotic plaque disruption has
been difficult to monitor because of the lack of an
animal model of plaque rupture. 23
 More than 30 years ago, Constantinides and
Chakravarti triggered plaque rupture and thrombosis
in aorta of chlolesterol fed rabbits by intraperitoneal
injection of Russell's viper venom (RVV, a potent
procoagulant and endothelial toxin) followed by the
intravenous injection of histamine, a vasopressor. 25
 The aortas of the rabbits were then accordingly
found to have disrupted atherosclerotic plaques with
overlying platelet-rich thrombi. 25
 The advantage of Constantinides model is use of
a biological intervention for triggering localized
plaque thrombosis. However the non-physiological
use of a toxic and potent thrombogenic substance
(snake toxin) to induce plaque thrombosis can be
considered a major drawback. 24
 Other disadvantages of the Constantinides model
are the low yield of triggering (only about one third
of the rabbits developed thrombosis) and the long
(8-month) preparatory period. 24
 Abela, Muller and colleagues challenged the
limitations of Constantinides model by having the
rabbits undergo aortic balloon injury followed by 8
weeks of 1% cholesterol diet. 24
 In addition, they wanted to determine whether
mechanical injury to the aorta early in the
preparatory phase could enhance the development
of vulnerable plaques, thereby increasing the yield
of disrupted plaques and shortening the preparatory
period. the rate of plaque disruption after
pharmacological triggering increased to 71%. 24
 They found that the rate of plaque disruption after
pharmacological triggering increased up to 71%.24
 Johnstone, Manning, and colleagues used the
modified Constantinides model and documented
plaque disruption by MRI that resemble those found
in human coronary arteries. 23
 A major advantage of the use of a rabbit over other
animals is that the rabbit’s aorta is approximately the
same anatomic size as the human coronary artery. 23
 As highlighted in this week of VP Watch,
Braun, Krieger, et al. showed that mice with
homozygous null mutations in the genes for
both the LDL and apoE receptors (SR-BI/apoE
double knockout mice) exhibit morphological
and functional defects with similarities to those
seen in human coronary heart disease.22
 The SR-BI/apoE dKO mice are distinct
because they have extensive coronary artery
lesions with fibrin deposition and
spontaneously develop extensive MIs on a
standard chow diet at a very young age (5
weeks).22
 The authors indicated that severe occlusive,
fibrin-containing coronary arterial lesions,
probable ischemia, multiple MIs, enlarged
hearts, and cardiac dysfunction in very young
('5 weeks old), low-fat/ low-cholesterol fed
SR-BI/apoE dKO mice provide a novel model
of CHD.22
 Fibrin deposits were found in the core regions
of 8 of 10 lesions in 3 of 3 dKO mice.22
 However, clear evidence for plaque rupture
was not found in these animals neither was
thin fibrous cap.22
Conclusion:
I. Comparing to the previous animal models of
atherosclerosis, double knockout LDL/apoE mice
seem to offer an improvement in studying the clinical
complications of atherosclerosis closer to human
ischemic heart disease.
II. However, it is unclear as to what degree the new
model simulates the pathophysiology and pathology
characteristic of human vulnerable atherosclerotic
plaques.
Questions:
1. Which one the following animal models more closely
resembles human coronary artery disease?
- Watanabe rabbits
- New Zealand cholesterol fed rabbits
- CETP/DS transgenic rat
- Apo-E deficient mice
- LDL deficient mice
- Double KO LDL/apoE mice
Questions:
2. Since clinical atherosclerosis is predominantly an
athero-thrombotic disease, besides the plaque
characteristics in these animals, the question is how
closely their blood factors and coagulation system
resembles of those in human?
3. Since transgenic animal models of atherosclerosis do
not live long, knowing the major role of age in the
natural history of human atherosclerosis and its
complications such as plaque rupture, can we find a
representative model of repeated plaque rupture in
these animals.
Suggestion:
VP.org Editorial Suggestion:
- Please email your thoughts to:
Discussion-Group@VP.org or DG@VP.org
1. Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, Keiser JA, Ryan MJ.
Animal model that mimics atherosclerotic plaque rupture. Circ Res. 1998 Oct 5;83(7):705-13.
2. Wong HY; The cockerel as an animal model for atherosclerosis research.
Adv Exp Med Biol. 1975;63:381-91.
3. Lucas A, Yue W, Jiang XY, Liu L, Yan W, Bauer J, Schneider W, Tulip J, Chagpar A, Dai E,
Perk M,Montague P, Garbutt M, Radosavljevic M. Development of an avian model for
restenosis. Atherosclerosis. 1996 Jan 5;119(1):17-41.
4. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its
elimination with aspirin. Circulation. 1976; 54: 365–370.
5. Anderson HV, McNatt J, Clubb FJ, Herman M, Maffrand JP, DeClerck F, Ahn C, Buja LM,
Willerson JT.; Platelet inhibition reduces cyclic flow variations and neointimal proliferation in
normal and hypercholesterolemic-atherosclerotic canine coronary arteries.; Circulation. 2001
Nov 6;104(19):2331-7.
6. Tesar GE, Kottke BA.; Location and sequence of atherosclerotic plaque formation in white
Carneau and show racer pigeons: reevaluation and redefinition.Arch Pathol Lab Med. 1978
Nov;102(11):581
7. Massmann J, Muller H, Weidenbach H, Wagner J, Krug H.; Relations between spontaneous
and induced arterial lesions in swine and arteriosclerosis in humans. Exp Pathol (Jena). 1977
Jul- Aug;14(1-2):89-99
8. Blaton V, Peeters H.; The nonhuman primates as models for studying human atherosclerosis:
studies on the chimpanzee, the baboon and the rhesus macacus.Adv Exp Med Biol.
1976;67(00):33-64.
9. Daum G, Pham J, Deou J.; Arsenite inhibits Ras-dependent activation of ERK but activates
ERK in the presence of oncogenic Ras in baboon vascular smooth muscle cells.; Mol Cell
Biochem. 2001 Jan;217(1-2):131-6.
References
10. Herrera VL, Makrides SC, Xie HX, Adari H, Krauss RM, Ryan US, Ruiz-Opazo N.;
Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in
Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein.;
Nat Med. 1999 Dec;5(12):1383-9.
11. Bennani-Kabchi N, Kehel L, el Bouayadi F, Fdhil H, Amarti A, Saidi A, Marquie G.; New model
of atherosclerosis in sand rats subjected to a high cholesterol diet and vitamin D2. Therapie.
1999 Sep-Oct;54(5):559-65.
12. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop
lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994
Jan;14(1):133-40.
13. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M.; Tranilast inhibits transplant-associated
coronary arteriosclerosis in a murine model of cardiac transplantation. Eur J Pharmacol. 2001
Dec 21;433(2-3):163-8.
14. Velleman SG, McCormick RJ, Ely D, Jarrold BB, Patterson RA, Scott CB, Daneshvar H,
Bacon WL. Collagen characteristics and organization during the progression of cholesterol-
induced atherosclerosis in Japanese quail. Exp Biol Med (Maywood). 2001 Apr;226(4):328-33.
15. Wu TC, Donaldson WE. Effect of cholesterol feeding on serum lipoproteins and
atherosclerosis in atherosclerosis-susceptible and atherosclerosis-resistant Japanese quail.
Poult Sci. 1982 Dec;61(12):2407-14.
16. Shih JC, Pullman EP, Kao KJ.; Genetic selection, general characterization, and histology of
atherosclerosis-susceptible and -resistant Japanese quail. Atherosclerosis. 1983 Oct;49(1):41-
53
References
17. Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim J-S, Gordon D, Keiser JA, Ryan MJ: Animal
model that mimics atherosclerotic plaque rupture. Circ.Res. 1998;83:705-713
18. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL.
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by
homologous recombination in ES cells. Cell. 1992 Oct 16;71(2):343-53.
19. Clubb FJ, Cerny JL, Deferrari DA, Butler-Aucoin MM, Willerson JT, Buja LM.
Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable
hyperlipidemic rabbit aortas.Cardiovasc Pathol. 2001 Jan-Feb;10(1):.
20. Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, Manning WJ.
In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model.
Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1556-60.
21. Wentzel JJ, Kloet J, Andhyiswara I, Oomen JA, Schuurbiers JC, de Smet BJ, Post MJ, de Kleijn D,
Pasterkamp G, Borst C, Slager CJ, Krams R.Shear-stress and wall-stress regulation of vascular
remodeling after balloon angioplasty: effect of matrix metalloproteinase inhibition.Circulation. 2001
Jul 3;104(1):91-6.
22. Anne Braun, Bernardo L. Trigatti, Mark J. Post, Kaori Sato, Michael Simons, Jay M. Edelberg,
Robert D. Rosenberg, Mark Schrenzel, and Monty Krieger Loss of SR-BI Expression Leads to the
Early Onset of Occlusive Atherosclerotic Coronary Artery Disease, Spontaneous Myocardial
Infarctions, Severe Cardiac Dysfunction, and Premature Death in Apolipoprotein E--Deficient Mice
Circulation Research published January 3, 2002, 10.1161/hh0302.104462
References
23. Michael T. Johnstone, René M. Botnar, Alexandra S. Perez, Robert Stewart, William C. Quist,
James A.
Hamilton, and Warren J. Manning; In Vivo Magnetic Resonance Imaging of Experimental
Thrombosis in
a Rabbit Model ; Arterioscler Thromb Vasc Biol 2001 21: 1556-1560.
24. George S. Abela, Paulo D. Picon, Stephan E. Friedl, Otavio C. Gebara, Akira Miyamoto,
Micheline
Federman, Geoffrey H. Tofler, and James E. Muller ; Triggering of Plaque Disruption and
Arterial
Thrombosis in an Atherosclerotic Rabbit Model; Circulation 1995 91: 776-784.
25. Constantinides P, Chakravarti RN. Rabbit arterial thrombosis production by systemic
procedures. Arch
Pathol. 1961;72:197-208.
26. Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage
and wall shear
rate on platelet deposition: ex vivo study in a swine model. Arteriosclerosis. 1986;6:312-
330.
27. Skinner MP, Yuan C, Mitsumori L, Hayes CE, Raines EW, Nelson JA, Ross R. Serial
magnetic
resonance imaging of experimental atherosclerosis detects lesion fine structure,
progression and
complications in vivo. Nat Med. . 1995; 1: 69–73.
References

More Related Content

What's hot

Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier
Kit Regulates HSC Engraftment across the Human-Mouse Species BarrierKit Regulates HSC Engraftment across the Human-Mouse Species Barrier
Kit Regulates HSC Engraftment across the Human-Mouse Species BarrierCarola Schäfer
 
New insights into leukemic niche in bone marrow
New insights into leukemic niche in bone marrowNew insights into leukemic niche in bone marrow
New insights into leukemic niche in bone marrownanog
 
Panos_NHLBI_Final Report
Panos_NHLBI_Final ReportPanos_NHLBI_Final Report
Panos_NHLBI_Final ReportJoseph Panos
 
Jc Rethinking Of Hsc Assays
Jc Rethinking Of Hsc AssaysJc Rethinking Of Hsc Assays
Jc Rethinking Of Hsc Assaysnanog
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaPete Shuster
 
Korc Poster Final 11 23 10
Korc Poster Final 11 23 10Korc Poster Final 11 23 10
Korc Poster Final 11 23 10Jack Crawford
 
Uremia and endothelial cells
Uremia and endothelial cellsUremia and endothelial cells
Uremia and endothelial cellskyste
 
Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...
Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...
Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...Liberty University (LU)
 
Canine hemangiosarcoma originates from hematopoietic precursors with potentia...
Canine hemangiosarcoma originates from hematopoietic precursors with potentia...Canine hemangiosarcoma originates from hematopoietic precursors with potentia...
Canine hemangiosarcoma originates from hematopoietic precursors with potentia...Rodrigo Shamed Cedillo Flores
 
Current Applications of Quasi Vivo
Current Applications of Quasi VivoCurrent Applications of Quasi Vivo
Current Applications of Quasi VivoSCIMS4
 

What's hot (13)

050 periadventitial fat
050 periadventitial fat050 periadventitial fat
050 periadventitial fat
 
journal.pone.0055095
journal.pone.0055095journal.pone.0055095
journal.pone.0055095
 
Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier
Kit Regulates HSC Engraftment across the Human-Mouse Species BarrierKit Regulates HSC Engraftment across the Human-Mouse Species Barrier
Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier
 
New insights into leukemic niche in bone marrow
New insights into leukemic niche in bone marrowNew insights into leukemic niche in bone marrow
New insights into leukemic niche in bone marrow
 
Panos_NHLBI_Final Report
Panos_NHLBI_Final ReportPanos_NHLBI_Final Report
Panos_NHLBI_Final Report
 
Jc Rethinking Of Hsc Assays
Jc Rethinking Of Hsc AssaysJc Rethinking Of Hsc Assays
Jc Rethinking Of Hsc Assays
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport Media
 
Korc Poster Final 11 23 10
Korc Poster Final 11 23 10Korc Poster Final 11 23 10
Korc Poster Final 11 23 10
 
Uremia and endothelial cells
Uremia and endothelial cellsUremia and endothelial cells
Uremia and endothelial cells
 
Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...
Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...
Effect of stemregenin1 and sb431542 small molecules on ex vivo expansion of u...
 
ResearchreportSTS
ResearchreportSTSResearchreportSTS
ResearchreportSTS
 
Canine hemangiosarcoma originates from hematopoietic precursors with potentia...
Canine hemangiosarcoma originates from hematopoietic precursors with potentia...Canine hemangiosarcoma originates from hematopoietic precursors with potentia...
Canine hemangiosarcoma originates from hematopoietic precursors with potentia...
 
Current Applications of Quasi Vivo
Current Applications of Quasi VivoCurrent Applications of Quasi Vivo
Current Applications of Quasi Vivo
 

Viewers also liked (16)

La web 2.0
La web 2.0La web 2.0
La web 2.0
 
Shirt Art PRO
Shirt Art PROShirt Art PRO
Shirt Art PRO
 
Practiquemos las relaciones humanas.
Practiquemos las relaciones humanas.Practiquemos las relaciones humanas.
Practiquemos las relaciones humanas.
 
Birkbeck Master of Science copy
Birkbeck Master of Science copyBirkbeck Master of Science copy
Birkbeck Master of Science copy
 
Soledad inscripcion
Soledad inscripcionSoledad inscripcion
Soledad inscripcion
 
Ashish
AshishAshish
Ashish
 
Taller Metropolitano 2016
Taller Metropolitano 2016Taller Metropolitano 2016
Taller Metropolitano 2016
 
A
AA
A
 
Iskra is hiring!
Iskra is hiring!Iskra is hiring!
Iskra is hiring!
 
Facebooking
FacebookingFacebooking
Facebooking
 
10g_OCP
10g_OCP10g_OCP
10g_OCP
 
10072015135030
1007201513503010072015135030
10072015135030
 
Fontys Transcript
Fontys TranscriptFontys Transcript
Fontys Transcript
 
Juliana guerra martinez
Juliana guerra martinezJuliana guerra martinez
Juliana guerra martinez
 
Las secuencias del sonido
Las secuencias del sonido Las secuencias del sonido
Las secuencias del sonido
 
Aemaxx--bathroom catalogue 2016
Aemaxx--bathroom catalogue 2016Aemaxx--bathroom catalogue 2016
Aemaxx--bathroom catalogue 2016
 

Similar to Vp watch editorial - v2 n2- 2002

222 animal models of heart attack
222 animal models of heart attack222 animal models of heart attack
222 animal models of heart attackSHAPE Society
 
animal models for evaluation of drugs for Cardiomyopathies
animal models for evaluation of drugs for Cardiomyopathies animal models for evaluation of drugs for Cardiomyopathies
animal models for evaluation of drugs for Cardiomyopathies samibhat5
 
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular DegenerationAHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular DegenerationAncestral Health Society
 
Red Blood Cell Hypoxia
Red Blood Cell HypoxiaRed Blood Cell Hypoxia
Red Blood Cell HypoxiaEsther Nasus
 
Angiogenesis, Introduction to Understand the Art.
Angiogenesis, Introduction to Understand the Art.Angiogenesis, Introduction to Understand the Art.
Angiogenesis, Introduction to Understand the Art.Khaled Elmasry
 
Proteins Of Bovine Red Blood Cell
Proteins Of Bovine Red Blood CellProteins Of Bovine Red Blood Cell
Proteins Of Bovine Red Blood CellKristi Lucas
 
Lymphatic drainage of head & neck
Lymphatic drainage of head & neckLymphatic drainage of head & neck
Lymphatic drainage of head & neckManish Kumar
 
Endothelial surface layer degradation by chronic
Endothelial surface layer degradation by chronicEndothelial surface layer degradation by chronic
Endothelial surface layer degradation by chronicmarconou1
 
j.1476-4431.2011.00624.x.pdf
j.1476-4431.2011.00624.x.pdfj.1476-4431.2011.00624.x.pdf
j.1476-4431.2011.00624.x.pdfleroleroero1
 
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...inventionjournals
 
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...inventionjournals
 
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...cordbloodsymposium
 
Am j physiol heart circ physiol 2000-matsubara-h1534-9
Am j physiol heart circ physiol 2000-matsubara-h1534-9Am j physiol heart circ physiol 2000-matsubara-h1534-9
Am j physiol heart circ physiol 2000-matsubara-h1534-9Natasha Xavier
 
Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?Apollo Hospitals
 
William bioreactor 2014
William bioreactor 2014William bioreactor 2014
William bioreactor 2014William
 

Similar to Vp watch editorial - v2 n2- 2002 (20)

222 animal models of heart attack
222 animal models of heart attack222 animal models of heart attack
222 animal models of heart attack
 
animal models for evaluation of drugs for Cardiomyopathies
animal models for evaluation of drugs for Cardiomyopathies animal models for evaluation of drugs for Cardiomyopathies
animal models for evaluation of drugs for Cardiomyopathies
 
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular DegenerationAHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
 
Red Blood Cell Hypoxia
Red Blood Cell HypoxiaRed Blood Cell Hypoxia
Red Blood Cell Hypoxia
 
Angiogenesis, Introduction to Understand the Art.
Angiogenesis, Introduction to Understand the Art.Angiogenesis, Introduction to Understand the Art.
Angiogenesis, Introduction to Understand the Art.
 
nature
naturenature
nature
 
8
88
8
 
fox2012 (1).pdf
fox2012 (1).pdffox2012 (1).pdf
fox2012 (1).pdf
 
Proteins Of Bovine Red Blood Cell
Proteins Of Bovine Red Blood CellProteins Of Bovine Red Blood Cell
Proteins Of Bovine Red Blood Cell
 
Lymphatic drainage of head & neck
Lymphatic drainage of head & neckLymphatic drainage of head & neck
Lymphatic drainage of head & neck
 
Endothelial surface layer degradation by chronic
Endothelial surface layer degradation by chronicEndothelial surface layer degradation by chronic
Endothelial surface layer degradation by chronic
 
j.1476-4431.2011.00624.x.pdf
j.1476-4431.2011.00624.x.pdfj.1476-4431.2011.00624.x.pdf
j.1476-4431.2011.00624.x.pdf
 
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
 
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
Nephrotic syndrome in Sickle Cell Disease of Western Odisha, India: A case re...
 
Hepatic Hydrothorax
Hepatic HydrothoraxHepatic Hydrothorax
Hepatic Hydrothorax
 
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
 
Am j physiol heart circ physiol 2000-matsubara-h1534-9
Am j physiol heart circ physiol 2000-matsubara-h1534-9Am j physiol heart circ physiol 2000-matsubara-h1534-9
Am j physiol heart circ physiol 2000-matsubara-h1534-9
 
Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?
 
Paper 14
Paper 14Paper 14
Paper 14
 
William bioreactor 2014
William bioreactor 2014William bioreactor 2014
William bioreactor 2014
 

More from Society for Heart Attack Prevention and Eradication

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Recently uploaded

bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhanthesalberry
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfNetHelix
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptxMrStavanUdayKadam
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxSizan Thapa
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxSizan Thapa
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedSBL DIGITAL
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxsiddharthroy26587
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptxnakera38
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfHongBiThi1
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionZeinabEmad3
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONojaswinihemane
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Dr. Dheeraj Kumar
 
clean rooms and its classification .pptx
clean rooms and its classification .pptxclean rooms and its classification .pptx
clean rooms and its classification .pptxushakiranmai4
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 

Recently uploaded (20)

bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhan
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdf
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptx
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptx
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptx
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), Addiction
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
 
clean rooms and its classification .pptx
clean rooms and its classification .pptxclean rooms and its classification .pptx
clean rooms and its classification .pptx
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 

Vp watch editorial - v2 n2- 2002

  • 1. Editorial Slides VP Watch, January 16, 2002, Volume 2, Issue 2 Part II - Animal Models of Heart Attack? Plaque Rupture/Thrombosis
  • 2. Part - I  Cell culture is a convenient way to ask mechanistic questions, but it lacks complexity of a real disease thus limiting the scope of testable hypotheses. Human observations provide rich soil for making hypotheses, but for obvious ethical reasons our ability to test these hypotheses in men is very limited. Animal models are essential for testing mechanistic hypotheses in a controlled manner.1  Ideal animal model is situated in the middle of this range. 1
  • 3. 1- Japanese quail 2- Pigeon 3- Chicken Reported Animal Models for Atherosclerosis 4- Dog 5- Monkey 6- Pig 7- Rat 8- Rabbit 9- Mouse
  • 4.  Quail: - Studies on Japanese quail have shown that the RES birds were resistant to the disease and developed little atherosclerosis on a diet containing 1% cholesterol. The SUS birds were sensitive and developed severe atherosclerosis in 8-9 wks on a diet containing only 0.5% cholesterol. 14,15,16
  • 5.  Pigeon: - Tesar and Kottke showed that two distinct types of fatty streaks can be identified in white Carneau pigeon and their biologic features can be defined and related to their propensity for atherogenesis.6
  • 6.  Chicken: - Wong discussed that chicken is a good animal model for the study of atherosclerosis research because it is able to develop spontaneous atherosclerosis and capable of producing atherosclerosis after cholesterol feeding with elevated hypercholesterolemia. There is no essential difference between vascular lesions seen in chickens as a result of cholesterol diet and that of atherosclerosis observed in man.2,3
  • 7.  Dog: - Reducing platelet accumulation at sites of balloon angioplasty may attenuate restenosis. Willerson, et al. tested this hypothesis by inducing repetitive platelet aggregation at coronary angioplasty sites in cholesterol sensitive dogs and measured subsequent neointima formation. 4,5
  • 8.  Monkey: - Blaton and Peeters discussed that the chimpanzee lipoproteins are useful models for understanding the relationship between function and structure of the plasma lipoproteins in health and disease. Baboon and rhesus monkeys show similar results, but more differences to the human lipoproteins in health and disease were observed.8,9
  • 9.  Swine: - Massmann, and others showed relations between spontaneous and induced arterial lesions in swine and arteriosclerosis in humans. 7,21
  • 10.  Rat: - Bennani-Kabchi et al. showed the potential of the sand rat to develop atherosclerotic lesions at different stages which opens the field to therapeutic tests of new anti-atherogenic agents. - More recently Herrera et al. demonstrated that cholesteryl ester transfer protein can be proatherogenic. The interaction of polygenic hypertension and hyperlipidemia in the pathogenesis of atherosclerosis in Tg [hCETP] DS rats substantiates epidemiological observations in humans.10,11
  • 11.  Rabbit: - Hereditary Watanabe rabbit - Clubb et al. evaluated temporal distribution of leukocytes, macrophages, foam cells, vascular smooth muscle cells, and subendothelial lipid in Watanabe heritable hyperlipedimic (WHHL) rabbit aortas.19 - Cholesterol fed New Zealand rabbit - Atherosclerotic plaques were produced in New Zealand White rabbits by intermittent cholesterol feeding.20
  • 12.  Rekhter, et al. have developed a rabbit model in which an atherosclerotic plaque can be ruptured at will after an inflatable balloon becomes embedded into the plaque. This model as well can be used for induction of thrombi associated with plaque rupture. 17
  • 13.  Mouse: - The apoE-deficient mouse contains the entire spectrum of lesions observed during atherogenesis and is the first mouse model to develop lesions similar to those in humans. 12,13
  • 14. Part - II  The process of atherosclerotic plaque disruption has been difficult to monitor because of the lack of an animal model of plaque rupture. 23  More than 30 years ago, Constantinides and Chakravarti triggered plaque rupture and thrombosis in aorta of chlolesterol fed rabbits by intraperitoneal injection of Russell's viper venom (RVV, a potent procoagulant and endothelial toxin) followed by the intravenous injection of histamine, a vasopressor. 25  The aortas of the rabbits were then accordingly found to have disrupted atherosclerotic plaques with overlying platelet-rich thrombi. 25
  • 15.  The advantage of Constantinides model is use of a biological intervention for triggering localized plaque thrombosis. However the non-physiological use of a toxic and potent thrombogenic substance (snake toxin) to induce plaque thrombosis can be considered a major drawback. 24  Other disadvantages of the Constantinides model are the low yield of triggering (only about one third of the rabbits developed thrombosis) and the long (8-month) preparatory period. 24
  • 16.  Abela, Muller and colleagues challenged the limitations of Constantinides model by having the rabbits undergo aortic balloon injury followed by 8 weeks of 1% cholesterol diet. 24  In addition, they wanted to determine whether mechanical injury to the aorta early in the preparatory phase could enhance the development of vulnerable plaques, thereby increasing the yield of disrupted plaques and shortening the preparatory period. the rate of plaque disruption after pharmacological triggering increased to 71%. 24  They found that the rate of plaque disruption after pharmacological triggering increased up to 71%.24
  • 17.  Johnstone, Manning, and colleagues used the modified Constantinides model and documented plaque disruption by MRI that resemble those found in human coronary arteries. 23  A major advantage of the use of a rabbit over other animals is that the rabbit’s aorta is approximately the same anatomic size as the human coronary artery. 23
  • 18.  As highlighted in this week of VP Watch, Braun, Krieger, et al. showed that mice with homozygous null mutations in the genes for both the LDL and apoE receptors (SR-BI/apoE double knockout mice) exhibit morphological and functional defects with similarities to those seen in human coronary heart disease.22  The SR-BI/apoE dKO mice are distinct because they have extensive coronary artery lesions with fibrin deposition and spontaneously develop extensive MIs on a standard chow diet at a very young age (5 weeks).22
  • 19.  The authors indicated that severe occlusive, fibrin-containing coronary arterial lesions, probable ischemia, multiple MIs, enlarged hearts, and cardiac dysfunction in very young ('5 weeks old), low-fat/ low-cholesterol fed SR-BI/apoE dKO mice provide a novel model of CHD.22  Fibrin deposits were found in the core regions of 8 of 10 lesions in 3 of 3 dKO mice.22  However, clear evidence for plaque rupture was not found in these animals neither was thin fibrous cap.22
  • 20. Conclusion: I. Comparing to the previous animal models of atherosclerosis, double knockout LDL/apoE mice seem to offer an improvement in studying the clinical complications of atherosclerosis closer to human ischemic heart disease. II. However, it is unclear as to what degree the new model simulates the pathophysiology and pathology characteristic of human vulnerable atherosclerotic plaques.
  • 21. Questions: 1. Which one the following animal models more closely resembles human coronary artery disease? - Watanabe rabbits - New Zealand cholesterol fed rabbits - CETP/DS transgenic rat - Apo-E deficient mice - LDL deficient mice - Double KO LDL/apoE mice
  • 22. Questions: 2. Since clinical atherosclerosis is predominantly an athero-thrombotic disease, besides the plaque characteristics in these animals, the question is how closely their blood factors and coagulation system resembles of those in human? 3. Since transgenic animal models of atherosclerosis do not live long, knowing the major role of age in the natural history of human atherosclerosis and its complications such as plaque rupture, can we find a representative model of repeated plaque rupture in these animals.
  • 23. Suggestion: VP.org Editorial Suggestion: - Please email your thoughts to: Discussion-Group@VP.org or DG@VP.org
  • 24. 1. Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, Keiser JA, Ryan MJ. Animal model that mimics atherosclerotic plaque rupture. Circ Res. 1998 Oct 5;83(7):705-13. 2. Wong HY; The cockerel as an animal model for atherosclerosis research. Adv Exp Med Biol. 1975;63:381-91. 3. Lucas A, Yue W, Jiang XY, Liu L, Yan W, Bauer J, Schneider W, Tulip J, Chagpar A, Dai E, Perk M,Montague P, Garbutt M, Radosavljevic M. Development of an avian model for restenosis. Atherosclerosis. 1996 Jan 5;119(1):17-41. 4. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 1976; 54: 365–370. 5. Anderson HV, McNatt J, Clubb FJ, Herman M, Maffrand JP, DeClerck F, Ahn C, Buja LM, Willerson JT.; Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.; Circulation. 2001 Nov 6;104(19):2331-7. 6. Tesar GE, Kottke BA.; Location and sequence of atherosclerotic plaque formation in white Carneau and show racer pigeons: reevaluation and redefinition.Arch Pathol Lab Med. 1978 Nov;102(11):581 7. Massmann J, Muller H, Weidenbach H, Wagner J, Krug H.; Relations between spontaneous and induced arterial lesions in swine and arteriosclerosis in humans. Exp Pathol (Jena). 1977 Jul- Aug;14(1-2):89-99 8. Blaton V, Peeters H.; The nonhuman primates as models for studying human atherosclerosis: studies on the chimpanzee, the baboon and the rhesus macacus.Adv Exp Med Biol. 1976;67(00):33-64. 9. Daum G, Pham J, Deou J.; Arsenite inhibits Ras-dependent activation of ERK but activates ERK in the presence of oncogenic Ras in baboon vascular smooth muscle cells.; Mol Cell Biochem. 2001 Jan;217(1-2):131-6. References
  • 25. 10. Herrera VL, Makrides SC, Xie HX, Adari H, Krauss RM, Ryan US, Ruiz-Opazo N.; Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein.; Nat Med. 1999 Dec;5(12):1383-9. 11. Bennani-Kabchi N, Kehel L, el Bouayadi F, Fdhil H, Amarti A, Saidi A, Marquie G.; New model of atherosclerosis in sand rats subjected to a high cholesterol diet and vitamin D2. Therapie. 1999 Sep-Oct;54(5):559-65. 12. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994 Jan;14(1):133-40. 13. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M.; Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation. Eur J Pharmacol. 2001 Dec 21;433(2-3):163-8. 14. Velleman SG, McCormick RJ, Ely D, Jarrold BB, Patterson RA, Scott CB, Daneshvar H, Bacon WL. Collagen characteristics and organization during the progression of cholesterol- induced atherosclerosis in Japanese quail. Exp Biol Med (Maywood). 2001 Apr;226(4):328-33. 15. Wu TC, Donaldson WE. Effect of cholesterol feeding on serum lipoproteins and atherosclerosis in atherosclerosis-susceptible and atherosclerosis-resistant Japanese quail. Poult Sci. 1982 Dec;61(12):2407-14. 16. Shih JC, Pullman EP, Kao KJ.; Genetic selection, general characterization, and histology of atherosclerosis-susceptible and -resistant Japanese quail. Atherosclerosis. 1983 Oct;49(1):41- 53 References
  • 26. 17. Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim J-S, Gordon D, Keiser JA, Ryan MJ: Animal model that mimics atherosclerotic plaque rupture. Circ.Res. 1998;83:705-713 18. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992 Oct 16;71(2):343-53. 19. Clubb FJ, Cerny JL, Deferrari DA, Butler-Aucoin MM, Willerson JT, Buja LM. Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas.Cardiovasc Pathol. 2001 Jan-Feb;10(1):. 20. Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, Manning WJ. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1556-60. 21. Wentzel JJ, Kloet J, Andhyiswara I, Oomen JA, Schuurbiers JC, de Smet BJ, Post MJ, de Kleijn D, Pasterkamp G, Borst C, Slager CJ, Krams R.Shear-stress and wall-stress regulation of vascular remodeling after balloon angioplasty: effect of matrix metalloproteinase inhibition.Circulation. 2001 Jul 3;104(1):91-6. 22. Anne Braun, Bernardo L. Trigatti, Mark J. Post, Kaori Sato, Michael Simons, Jay M. Edelberg, Robert D. Rosenberg, Mark Schrenzel, and Monty Krieger Loss of SR-BI Expression Leads to the Early Onset of Occlusive Atherosclerotic Coronary Artery Disease, Spontaneous Myocardial Infarctions, Severe Cardiac Dysfunction, and Premature Death in Apolipoprotein E--Deficient Mice Circulation Research published January 3, 2002, 10.1161/hh0302.104462 References
  • 27. 23. Michael T. Johnstone, René M. Botnar, Alexandra S. Perez, Robert Stewart, William C. Quist, James A. Hamilton, and Warren J. Manning; In Vivo Magnetic Resonance Imaging of Experimental Thrombosis in a Rabbit Model ; Arterioscler Thromb Vasc Biol 2001 21: 1556-1560. 24. George S. Abela, Paulo D. Picon, Stephan E. Friedl, Otavio C. Gebara, Akira Miyamoto, Micheline Federman, Geoffrey H. Tofler, and James E. Muller ; Triggering of Plaque Disruption and Arterial Thrombosis in an Atherosclerotic Rabbit Model; Circulation 1995 91: 776-784. 25. Constantinides P, Chakravarti RN. Rabbit arterial thrombosis production by systemic procedures. Arch Pathol. 1961;72:197-208. 26. Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition: ex vivo study in a swine model. Arteriosclerosis. 1986;6:312- 330. 27. Skinner MP, Yuan C, Mitsumori L, Hayes CE, Raines EW, Nelson JA, Ross R. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. . 1995; 1: 69–73. References